News & Events

Vivli Executive Director Dr. Rebecca Li to speak at HRB-Trials Methodology Research Network Webinar

Health Research Board Trials Methodology Research Network (HRB TMRN) will be featuring Vivli’s Executive Director, Dr. Rebecca Li, on their upcoming webinar, “Implementation of Data Sharing platforms and How Researchers are Utilizing these Platforms to Further their Research.”

The HRB-Trials Methodology Research Network (HRB-TMRN) is a collaborative initiative between a number of Irish and international higher education institutes and methodology centers.

Its’ mission is to strengthen the methodology and reporting of trials in health and social care in Ireland so that they become more relevant, accessible and influential for patients and other service users, practitioners, policy makers and the public. This is achieved through a program of work relating to the methodology of trials and focused on (i) support (ii) training and education (iii) research and innovation and (iv) public engagement.

Register for Dr. Li’s presentation, which takes place Monday, April 12th 9:00-10:00 EDT (2:00-3:00pm GMT), and learn more here.

Wellcome Trust awards Vivli grant to improve access to Covid-19 clinical trial data

Vivli has received a grant from the Wellcome Trust, which aims to improve the access and re-use of COVID-related clinical trials data. This will include data from trials funded by the Coronavirus Therapeutics Accelerator (CTA), an initiative launched by the Bill & Melinda Gates Foundation, Wellcome and Mastercard to speed up the response to the Covid-19 pandemic by identifying, assessing, developing, and scaling up Covid-19 treatments. Vivli has received these funds as part of the consortium’s efforts to encourage and enhance the sharing of COVID-19 data.

“Vivli is delighted that we have received this timely grant from the Wellcome Trust as it will serve to enhance our ongoing efforts in COVID to accelerate access,” said Rebecca Li, Vivli Executive Director. “Coronavirus is currently the most searched term on our Vivli platform.”

Additionally, the grant will help Vivli improve its existing infrastructure to make studies that are available on Vivli easier to find and surface more data usage metrics. In addition, the grant provides funding for Vivli to work with the Infectious Disease Data Observatory (IDDO) to make COVID studies in its platform also available for searching and requesting on Vivli.

The grant will provide funding over a three-year period. Insight Enterprises, Vivli’s long-time partner, will undertake the technical enhancements on the Vivli platform that are linked to this grant.


About Vivli

Vivli is a non-profit organization working to advance human health through the insights and discoveries gained by sharing and analyzing data. It is home to an independent global data-sharing and analytics platform which serves all elements of the international research community. The platform includes a data repository, in-depth search engine and cloud-based analytics, and harmonizes governance, policy and processes to make sharing data easier. Vivli acts as a neutral broker between data contributor and data user and the wider data sharing community. For more information, visit www.vivli.org and follow us on Twitter @VivliCenter.

About IDDO

Launched in 2016, the Infectious Diseases Data Observatory (IDDO) is a scientifically independent, multi-disciplinary coalition of the global infectious disease community. It provides an environment for equitable data sharing as well as the methods and infrastructure to harmonise and translate data into evidence that improves outcomes for patients worldwide. IDDO builds on and incorporates the pioneering work of the WorldWide Antimalarial Resistance Network (WWARN), a collaborative data-sharing framework begun in 2009 that proved it was possible to produce policy-changing scientific evidence from historical data.

Vivli releases latest version of its platform

We are delighted to announce the latest release of the Vivli platform, version 1.7, which has several new features including an updated suite of tools and software available in the research environment, greater flexibility in the data upload process and improved reporting.

We have updated the complete suite of tools and software available in Vivli’s research environment to reflect these changes. Any researcher environments provisioned after March 6, 2021 date will have this software included as standard and existing research environments can have these updated software and packages included upon request.

Reach out to support@vivli.org for more information.

Vivli’s Executive Director and Director of Strategy and Operations to present at Clinical Data Disclosure, Transparency and Plain Language Summaries Virtual Conference

InformaConnect will be combining their EU and US events into one global virtual event this year: the Clinical Data Disclosure, Transparency & Plain Language Summaries, May 10th – May 12th. Participants can expect to learn from thought-leaders and innovators across the industry in this three-day event that covers topics:

  • Global clinical transparency regulations and data sharing
  • Harmonization, data sharing requirements and COVID-19 learnings
  • Plain language summaries, dissemination strategies and publications

Registration is free for patients and clinical investigators, and members of pharma companies, biotech companies, medical device, government body, non-profit and academic institutions.

Dr. Li be participating in the panel, “Balancing Sharing Results and Data Whilst Protecting Participants Data Privacy,” on May 10th and Julie Wood will be a part of the presentation, “Considerations for sponsors when using a Data Sharing Platform – Vivli as a case study,” on May 11th. Register today and learn more about other sessions in the conference here.

Vivli to host webinar: Clinical Trial Data Sharing and Machine Learning Research

Join Vivli for a webinar to learn about how Machine Learning (ML) research approaches may be used in the context of clinical data re-use.

These approaches raise important questions and opportunities for data sharing. Panelists will provide an overview of machine learning including case studies from Vivli (a global data sharing and analytics platform) where we have received requests from investigators requesting to obtain anonymized data to utilize machine learning approaches to conduct secondary analyses of data. Challenges and legal issues will be presented, and panelists will reflect on opportunities to work together on these issues to continue to move forward towards scientific discovery.

Join us as we explore where ML fits in with the future of secondary analysis and how we can optimize its approach.

The webinar will be held on March 23rd at 9:00 am PT / 12:00 pm ET / 5:00 pm GMT.

Recording

Key topics to be covered:

  • Machine Learning research approaches, and its similarity and differences to other statistical methods
  • Legal issues around ML and how they can be overcome
  • Machine Learning case studies

Panelists include: 

Ida Sim, UCSF and Vivli
Abigail Gregor, Ropes & Gray
Daniel Freshmen, Ropes & Gray

Vivli names remaining 9 Global Data Sharing Innovator Award Winners

In 2018, Vivli launched its first data analysis challenges to encourage researchers to search and request studies available on the Vivli platform. Since then, we have had received more than 250 requests.

Early last year, Vivli was excited to name ten Pioneer Winners – the first lead investigators whose data requests were successfully approved—and its first Global Data Sharing Innovator. We are excited to announce today our final nine Global Data Sharing Innovators.

Global Data Sharing Innovators are the first ten data requests that complete and publish their analysis in a peer-reviewed journal. Lead investigators of the data request team are recognized with this award and the opportunity to present the results of their research at a future global Vivli Data Sharing meeting.

 

The winners and their affiliated institution at the time of publication are:

Ahmad Abuhelwa, University of South Australia

Maria Alice Franzoi, Jules Bordet Institut

Chris Gale, University of Leeds

Laure Gossec, Sorbonne Université

Akira Kimata, University of Tsukuba

Thomas Metkus, Johns Hopkins University School of Medicine

José António Pereira da Silva, Universidade de Coimbra, Portugal

Sharon Straus, St. Michael’s Hospital

Michael Szarek, SUNY Downstate Medical Center

 

View a summary of publications made as a result of research requests made on the Vivli platform.

Vivli waives data contribution fees for researchers located in low-and-middle-income countries

 

Vivli has waived fees associated with data contributions from academic researchers located in low-and-middle-income countries.

“We decided to waive these fees as it was important to remove financial barriers to data sharing,” said Rebecca Li, Executive Director of Vivli.

Learn more about the process in How to Share Data. For researchers that have any questions, please contact Vivli directly by emailing support@vivli.org

Vivli Co-founder Dr. Ida Sim to speak at CBMRT’s Transparency Summit Series

Center for Biomedical Research Transparency (CBMRT) is hosting its fourth annual global summit series with the intention to engage a diverse group of participants with a passion for increasing transparency in research practices. CBMRT will host a virtual Summit series with short sessions scheduled for February 26, March 16 and March 26.

Participants can expect a very engaged discussion on topics including research integrity, global open access policy developments, and transparency implications of research acceleration. Presentations will be deliberately brief (but content rich) to allow ample time for productive discussions to ensue.

Training videos for researchers available on YouTube

Vivli is delighted to launch the first in a series of training videos aimed at researchers interested in accessing individual participant level data (IPD).

These short and informative data sharing videos can help a first-time requester of data or a more experienced secondary analysis researcher. Topics include:

• What is typically provided in the data package? How do these documents inter-relate?
• Why are data anonymized prior to sharing and how might this affect my analysis?
• Case examples of where key information may be located in the relevant data documents

For additional ideas for our next series of training videos contact:
Info@vivli.org

If you are interested in starting a search for individual participant level data from clinical trials please see www.vivliorg.kinsta.cloud

These videos are open for use by the data sharing community. Please share them widely.

What are the Supporting Documents Provided Along with the IPD?

Why is the Data Anonymized/De-Identified Prior to Sharing?

What is a Clinical Study Report (CSR)?

Kyowa Kirin joins Vivli as its newest member

“We are delighted to announce that global specialty pharmaceutical company, Kyowa Kirin, has joined Vivli as a member,” said Rebecca Li, Vivli Executive Director.

Kyowa Kirin strives to contribute to the health and well-being of people around the world through cutting-edge, technology-driven science, and will provide data focused on four key therapeutic areas: Nephrology, Oncology, Immunology & Allergy and Central Nervous System.

For more information about the data Kyowa Kirin will share on Vivli, please visit the member page. For additional information about Vivli membership, learn more here.